Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Iovance Biotherapeutics, Inc. - Common Stock (NQ:IOVA)

3.130 +0.640 (+25.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Iovance Biotherapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Why Replimune's Surprise Rejection Rattled Wall Street, And Cratered Its Stock
The company had lined up a priority review in the hopes of winning an accelerated approval for its melanoma treatment. 
Via Investor's Business Daily
D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
This Healthcare Stock Just Hit a 52-Week Low -- but Wall Street Sees 380% Upside
Via The Motley Fool
Earnings Scheduled For May 8, 2025
Via Benzinga
Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Is This Beaten-Down Stock a Millionaire Maker?
Via The Motley Fool
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value 
Via MarketBeat
Topics Artificial Intelligence Economy
Why Iovance Biotherapeutics Stock Dove by Almost 15% This Week
Via The Motley Fool
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
Via The Motley Fool
Topics Economy Law Enforcement
Down More Than 75% This Year, Should Investors Throw in the Towel on Iovance Biotherapeutics Stock?
Via The Motley Fool
Why Iovance Biotherapeutics Tumbled by Nearly 6% Today
Via The Motley Fool
This Foot Locker Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday
Via Benzinga
Is This Beaten-Down Stock a Buy Near Its 52-Week Low?
Via The Motley Fool
3 Monster Stocks in the Making
Via The Motley Fool
Top movers in Friday's session
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
Keep an eye on the top gainers and losers in Friday's session.
Wondering how the US markets performed in the middle of the day on Friday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
The market is filled with gapping stocks in Friday's session.
The session on Friday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session. 
Via Chartmill
Why Iovance Biotherapeutics Stock Is Crashing Today
Via The Motley Fool
Wondering what's happening in today's pre-market session?
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session. 
Via Chartmill
Expert Outlook: Iovance Biotherapeutics Through The Eyes Of 9 Analysts
Via Benzinga
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Dave To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Uncovering Potential: Iovance Biotherapeutics's Earnings Preview
Via Benzinga
My 3 Favorite Stocks to Buy Right Now
There are plenty of good ones to choose from, but these three are all undervalued, leaving them ripe for a lot of bullishness sooner than later. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.